As per MRFR analysis, the US Continuous Glucose Monitoring System Market Size was estimated at 1.04 (USD Billion) in 2023. The US Continuous Glucose Monitoring System Market is expected to grow from 1.15 (USD Billion) in 2024 to 3 (USD Billion) by 2035. The US Continuous Glucose Monitoring System Market CAGR (growth rate) is expected to be around 9.108% during the forecast period (2025 - 2035).
Key US Continuous Glucose Monitoring System Market Trends Highlighted
A number of important factors are driving the market for continuous glucose monitoring systems in the US. The rising incidence of diabetes, especially Type 1 and Type 2, is a major factor that has increased demand for sophisticated monitoring systems.
Millions of Americans have diabetes, according to the American Diabetes Association, which increases the demand for more accurate and effective glucose management devices like CGMs. There is a chance to investigate ways to make things easier to use and integrate with smartphone apps for real-time monitoring as technology develops.
For both patients and healthcare professionals, this can simplify the management of diabetes. CGMs are customized to meet the needs of each patient, following a discernible trend in healthcare towards personalization in recent years.
The requirement for more dependable and user-friendly equipment is met by innovations including longer wear times and improved sensor accuracy. Additionally, regulatory assistance from agencies such as the FDA has expedited product approvals, creating an atmosphere that is favorable for market expansion.
Patients may now better manage their conditions from the comfort of their homes thanks to new options brought about by the trend towards telehealth and remote patient monitoring. Additionally, diabetes self-management education and awareness initiatives are gaining momentum, which might increase market penetration as more people learn about the advantages of CGMs.
Exciting opportunities for the future of diabetes care in the US are also presented by the integration of CGMs with health data platforms and ongoing advancements in device connection, which will eventually improve patient outcomes and the effectiveness of healthcare as a whole.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
US Continuous Glucose Monitoring System Market Drivers
Increasing Prevalence of Diabetes in the United States
The rising prevalence of diabetes in the United States is one of the most significant drivers of growth in the US Continuous Glucose Monitoring System Market. According to the Centers for Disease Control and Prevention (CDC), as of 2020, approximately 34.2 million Americans had diabetes, accounting for about 10.5 percent of the population.
This figure represents a substantial increase from previous years, indicating a growing need for effective management solutions such as continuous glucose monitors.
Established organizations like the American Diabetes Association (ADA) advocate for the adoption of advanced glucose monitoring technologies, which aligns with the increasing patient needs for precise and convenient blood sugar management.
As diabetes cases are projected to rise further, the demand for continuous glucose monitoring systems will continue to gain momentum, driving market growth significantly in the upcoming years.
Technological Advancements in Continuous Glucose Monitoring Systems
Technological advancements significantly impact the US Continuous Glucose Monitoring System Market by enhancing device accuracy and user experience. Innovations such as smaller sensor sizes, longer wear times, and smartphone integrations have made continuous glucose monitors more appealing to consumers.
According to the Food and Drug Administration (FDA), new technologies have been successfully approved that allow real-time data sharing and cloud-based analytics, providing patients with valuable insights into their glucose levels.
Companies like Abbott Laboratories and Dexcom are at the forefront of these advancements, demonstrating how modern solutions can significantly improve the quality of life for diabetic patients. As these technologies become more widespread, it will likely lead to increased adoption and sustained market growth.
Rising Awareness and Education Regarding Diabetes Management
There is a growing awareness among the US population regarding diabetes management, which significantly contributes to the growth of the US Continuous Glucose Monitoring System Market.
Initiatives by organizations like the American Association of Clinical Endocrinology (AACE) aim to educate patients about diabetes management tools, including continuous glucose monitoring systems. According to estimates from AACE, nearly 50% of people with diabetes do not use effective monitoring tools.
However, as informed patients begin to understand the benefits and accuracy of continuous glucose monitoring, adoption rates are increasing. This heightened awareness drives demand for innovative monitoring solutions, creating opportunities for market players and contributing to overall industry growth.
Growing Geriatric Population in the United States
The increasing geriatric population in the United States presents another significant driver for the US Continuous Glucose Monitoring System Market. As per the US Census Bureau, the number of individuals aged 65 and older is projected to reach over 80 million by 2040, doubling currently estimated figures. Older adults are at a greater risk of developing diabetes and require more effective monitoring options.
Organizations such as the American Geriatrics Society are advocating for better diabetes care management tools among the elderly, promoting the need for continuous glucose monitoring systems. This demographic shift signals a growing market potential, necessitating the development of tailored solutions to cater to the needs of this expanding segment.
US Continuous Glucose Monitoring System Market Segment Insights
Continuous Glucose Monitoring System Market Application Insights
The Application segment of the US Continuous Glucose Monitoring System Market plays a pivotal role in addressing various health management needs.
This segment is primarily significant for Diabetes Management, where Continuous Glucose Monitoring (CGM) systems are crucial for real-time tracking of glucose levels, thus allowing individuals to make informed decisions regarding insulin administration and dietary habits.
As the prevalence of diabetes continues to rise in the US, driven by factors like an increase in obesity and sedentary lifestyles, this segment has seen significant expansion, with technologies making it more accessible and user-friendly.
In Critical Care settings, CGM systems enable healthcare providers to monitor patients’ glucose levels continuously, which is essential for managing patients in emergency or intensive care situations. The capability to track glucose levels accurately aids in preventing complications and facilitates timely interventions.
Moreover, the Sports Nutrition aspect of the Application segment is gaining traction, as athletes and fitness enthusiasts use CGM systems to optimize their performance through better glucose management.
This growing awareness around nutrition and health among athletes, alongside the increasing focus on personalized fitness regimens, is propelling innovations in CGM technologies tailored for sports applications.
Overall, this segment addresses a wide range of health applications, underlining its importance in the US market, with advancements in technology driving growth and improving lives across different demographics.
The US market sees a unique blend of therapeutic utilization in diabetes care and preventive measures in sports nutrition, showcasing how Continuous Glucose Monitoring systems can have diverse applications, thus emphasizing their versatility and relevance in today’s health landscape.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Continuous Glucose Monitoring System Market Product Type Insights
The US Continuous Glucose Monitoring System Market is prominently segmented into several Product Types, which include Sensors, Transmitters, Receivers, and Integrated Devices. Each of these segments plays a crucial role in the overall functioning and effectiveness of glucose monitoring systems. Sensors are essential as they provide real-time glucose readings, allowing for timely interventions.
Transmitters facilitate the wireless communication of glucose data from the sensor to the receiver, enhancing user convenience and real-time monitoring. Receivers are critical, serving as the display devices for the glucose readings and helping users track their data efficiently.
Integrated devices combine these functions, offering a streamlined solution that appeals to users looking for a comprehensive monitoring experience. The growth in the prevalence of diabetes in the US, driven by factors such as dietary habits and sedentary lifestyles, is propelling the demand for these products.
Moreover, advancements in technology are continuously improving the accuracy and usability of these devices, drawing attention from both healthcare providers and patients.
As awareness about diabetes management grows, these segments are expected to gain significant traction, enhancing accessibility and encouragement towards effective glucose monitoring solutions. Challenges such as affordability and technological limitations remain, but the market presents numerous opportunities for innovation and improved patient care.
Continuous Glucose Monitoring System Market End-user Insights
The US Continuous Glucose Monitoring System Market is experiencing substantial growth across various End-users, reflecting the increasing prevalence of diabetes and the demand for better glucose management solutions.
Hospitals play a crucial role in this ecosystem by utilizing advanced CGM systems to enhance patient care in acute settings, improving clinical outcomes and patient safety during hospitalization. Homecare segments are also gaining prominence, with patients preferring convenient solutions for monitoring their glucose levels from the comfort of their homes, thus promoting better adherence to management plans.
Diabetes clinics provide specialized support and education, leading to tailored treatment plans that integrate CGM technology, which aids in more effective diabetes management.
Together, these End-users are vital in expanding the reach of Continuous Glucose Monitoring System services, each contributing uniquely to the overall market dynamics, while addressing the needs of diverse patient populations and driving improvements in diabetes care across the United States.
As more innovations emerge, the role of these segments will continue to evolve, creating opportunities for better health outcomes and higher quality of life for individuals with diabetes.
Continuous Glucose Monitoring System Market Technology Insights
The US Continuous Glucose Monitoring System Market is evolving significantly within the Technology segment, showcasing a variety of advanced methodologies that cater to the growing demand for effective glucose management solutions.
Microdialysis emerges as an important technique known for its ability to provide continuous monitoring and real-time data, making it valuable for diabetes management. Spectroscopy is also gaining traction, offering non-invasive glucose monitoring options that can enhance patient compliance and ease of use, thus representing a growing preference among users.
The electrochemical approach dominates the landscape due to its cost-effectiveness and reliability, appealing to both healthcare providers and patients alike. The combination of these technologies responds to increasing demand in the US, driven by factors such as the rising prevalence of diabetes and the need for continuous health monitoring solutions.
Additionally, there are regulatory efforts focused on enhancing the approval processes for innovative devices, which may further propel the advancements in these technologies within the US market.
US Continuous Glucose Monitoring System Market Key Players and Competitive Insights
The US Continuous Glucose Monitoring System Market is undergoing significant transformation, driven by advancements in technology, increasing prevalence of diabetes, and a growing emphasis on personalized healthcare. Competitive insights in this sector reveal a dynamic landscape where innovation and strategic partnerships play pivotal roles in shaping market trends.
Companies are aggressively developing solutions that not only provide real-time glucose monitoring but also integrate data analytics and mobile applications for a comprehensive management platform. The market is characterized by a mix of established players and emerging startups, all striving to capture market share within a landscape that increasingly prioritizes user experience and healthcare outcomes.
As consumers become more informed and proactive in managing their health, the competition intensifies, prompting companies to enhance their product offerings and invest in research and development. In the US market, Freestyle stands out for its robust lineup of continuous glucose monitoring products that cater to a diverse demographic of users, ranging from children to adults.
The company has established a strong brand presence by emphasizing ease of use and accuracy of its devices. Freestyle's strengths lie in its innovative technology that allows for minimally invasive glucose monitoring, providing users with real-time data that is both accessible and actionable.
Moreover, the user-friendly interface of Freestyle devices encourages greater engagement and adherence among users, enhancing overall diabetes management. The commitment to continuous improvement and customer feedback has enabled Freestyle to build a loyal customer base while also capturing the attention of healthcare professionals who recommend its products for reliable glucose monitoring solutions.
Medtronic, a prominent player in the US Continuous Glucose Monitoring System Market, offers an extensive range of products and services that meet the diverse needs of insulin-dependent diabetes patients.
Known for its flagship continuous glucose monitoring systems, Medtronic combines advanced sensor technology with integrated insulin delivery solutions to provide a comprehensive diabetes management platform.
The company’s strengths include a significant investment in research and development, enabling it to introduce cutting-edge technologies that improve the accuracy and reliability of glucose readings. Medtronic’s strategic mergers and acquisitions have further solidified its market presence, allowing it to enhance its product offerings and expand its customer reach.
By focusing on patient-centric innovations and establishing partnerships with healthcare providers, Medtronic aims to enhance the quality of life for diabetes patients while solidifying its status as a leader in the continuous glucose monitoring space in the United States.
Key Companies in the US Continuous Glucose Monitoring System Market Include:
US Continuous Glucose Monitoring System Market Developments
In recent months, the US Continuous Glucose Monitoring System Market has experienced significant advancements and developments. Notably, Abbott Laboratories has reported growth in their FreeStyle Libre technology, with a wider acceptance among diabetic patients leading to a substantial increase in market share in the sector as of September 2023.
Medtronic has also introduced its latest continuous glucose monitoring systems, which integrate with insulin pumps, reflecting the trend toward more integrated diabetes management solutions. In August 2023, Dexcom announced a partnership to enhance its data-sharing capabilities, further increasing the efficacy of diabetes management for users.
Additionally, in May 2023, a merger between Ascensia Diabetes Care and Ypsomed was made public, allowing for the development of more innovative solutions in the CGM space. The US market is witnessing a rising demand for wearable glucose monitoring devices due to the increasing prevalence of diabetes; as of 2022, an estimated 37 million Americans are living with diabetes.
The valuation of the continuous glucose monitoring market has also reached around $4 billion, indicating robust growth potential and significant investments in new technologies and research by companies such as Johnson and Johnson, Becton Dickinson, and Tandem Diabetes Care.
US Continuous Glucose Monitoring System Market Segmentation Insights
| Report Attribute/Metric | Details |
| Market Size 2023 | 1.04(USD Billion) |
| Market Size 2024 | 1.15(USD Billion) |
| Market Size 2035 | 3.0(USD Billion) |
| Compound Annual Growth Rate (CAGR) | 9.108% (2025 - 2035) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Freestyle, Medtronic, Abbott Laboratories, Dexcom, Senseonics, Ascensia Diabetes Care, Ypsomed, Roche, Tandem Diabetes Care, Insulet Corporation, Johnson and Johnson, Becton Dickinson |
| Segments Covered | Application, Product Type, End-user, Technology |
| Key Market Opportunities | Rising diabetes prevalence, Technological advancements in sensors, Increasing demand for telehealth solutions, Growing awareness among patients, Integration with mobile health apps |
| Key Market Dynamics | Increasing diabetes prevalence, Technological advancements, Rising awareness and adoption, Cost-effectiveness of monitoring, Expanding insurance coverage |
| Countries Covered | US |
Frequently Asked Questions (FAQ) :
In 2024, the US Continuous Glucose Monitoring System Market was valued at 1.15 billion USD.
By 2035, the market is expected to reach a value of 3.0 billion USD.
The market is projected to grow at a CAGR of 9.108% during the period from 2025 to 2035.
The Diabetes Management application segment held the largest market share, valued at 0.7 billion USD in 2024.
The Critical Care application segment is projected to be valued at 0.75 billion USD by 2035.
Major players in the market include Freestyle, Medtronic, Abbott Laboratories, and Dexcom, among others.
The Sports Nutrition application segment is expected to grow to a value of 0.45 billion USD by 2035.
The increasing prevalence of diabetes and advancements in technology are contributing to market growth.
The market faces challenges such as high costs of devices and varying reimbursement policies.
There are opportunities to develop new technologies and expand applications for different demographics.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
